SciELO - Scientific Electronic Library Online

 
vol.69 número2Alergia a la vacuna Pfizer-BioNTech® demostrada mediante pruebas cutáneasLugol como causa inusual de anafilaxia después de la colposcopia. Reporte de un caso clínico índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista alergia México

versión On-line ISSN 2448-9190

Resumen

GALVEZ-ROMERO, José Luis et al. Rhino-orbital mucormycosis in a Mexican patient with COVID-19: Case report. Rev. alerg. Méx. [online]. 2022, vol.69, n.2, pp.93-97.  Epub 17-Feb-2023. ISSN 2448-9190.  https://doi.org/10.29262/ram.v69i2.1185.

Background:

A variety of bacterial and fungal co-infections may be attributed to the coronavirus disease 2019 (COVID-19), particularly in people who already have a medical condition such diabetes mellitus or those who received large dosages of steroids.

Case report:

We described a 52-year-old diabetic man who was receiving high doses of dexamethasone and antibiotics while receiving ambulatory care for COVID-19 pneumonia. His anterior rhinoscopy revealed a necrotic scab, and a sample confirmed Mucor spp. He underwent surgery and was given amphotericin as a result of the severity of the condition, palpebral ptosis, and right ocular palsy he was experiencing. The patien´s progression was satisfactory.

Conclusions:

pre-existing diabetes mellitus, previous steroid and antimicrobial use, as well as SARS-CoV-2 infection are some of the risk factors associated with Mucor spp. infection. Prompt detection of mucormycosis is important in the management of these affected patients.

Palabras llave : SARS-CoV-2; Invasive fungal infections; PostCOVID-19 mucormycosis.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )